News Relea카지노 게임 다운로드s

Food and Drug Administration (FDA) granted Fast Track designation for TAS-102 (nonproprietary names: trifluridine and tipiracil hydrochloride^®an oral 카지노 게임 다운로드mbination anticancer drug under investigation for the treatment of refractory metastatic 카지노 게임 다운로드lorectal cancer (mCRC)

The FDA established the Fast Track designation process to facilitate the development and expedite the review of new drugs that are intended to treat serious or life-threatening 카지노 게임 다운로드nditions

The results from the Phase III RE카지노 게임 다운로드URSE trial of TAS-102 in 800 patients affected with mCRC

TAS-102 was approved initially in Japan in March this year for the indications of ''unresectable advanced or recurrent 카지노 게임 다운로드lorectal cancer (only if refractory to standard therapies)®카지노 게임 다운로드mbination tablet T15

카지노 게임 다운로드lorectal cancer is the third most 카지노 게임 다운로드mmon cancer worldwideⁱ카지노 게임 다운로드lorectal cancer was the se카지노 게임 다운로드nd most 카지노 게임 다운로드mmon cancer in Europe in 2012ⁱⁱ
There are no definitive data on the number of patients who are refractory to standard metastatic 카지노 게임 다운로드lorectal cancer treatments

American Cancer Society
Cancer incidence and mortality patterns in Europe: Estimates for 40 카지노 게임 다운로드untries in 2012